Oct 13 (Reuters) - Immuron Ltd IMC.AX :
* IMMURON STRATEGIC INVESTMENT IN LEADING GUT HEALTH BIOTECH
ATERIA HEALTH
* IMMURON SAYS INTENTION TO ENTER INTO RECIPROCAL
DISTRIBUTION
AGREEMENT FOR TRAVELAN® IN U.K. MARKET AND JUVIA™ IN AUSTRALIAN
AND NORTH AMERICAN MARKETS
* UPFRONT CASH INVESTMENT OF £1.48M FUNDED FROM IMMURON'S
EXISTING
CASH RESERVES
* NET PROCEEDS WILL BE USED BY ATERIA FOR PRODUCT LAUNCH AND
ONGOING PRODUCT MARKETING OF JUVIA
* NET PROCEEDS WILL BE USED BY ATERIA RESEARCH AND
DEVELOPMENT
(FURTHER CLINICAL TRIALS) FOR JUVIA PRODUCTS
Source text for Eikon: ID:nGNX1S9rJC
Further company coverage: IMC.AX